REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 167 filers reported holding REGENXBIO INC in Q3 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $319,000 | +13.9% | 8,200 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $280,000 | -25.7% | 8,200 | -1.4% | 0.00% | -40.0% |
| Q4 2020 | $377,000 | +64.6% | 8,320 | 0.0% | 0.01% | +66.7% |
| Q3 2020 | $229,000 | -84.6% | 8,320 | -79.4% | 0.00% | -85.7% |
| Q2 2020 | $1,485,000 | +13.7% | 40,320 | 0.0% | 0.02% | 0.0% |
| Q1 2020 | $1,306,000 | -17.0% | 40,320 | 0.0% | 0.02% | +31.2% |
| Q4 2019 | $1,573,000 | +7.9% | 40,320 | -1.5% | 0.02% | 0.0% |
| Q3 2019 | $1,458,000 | -30.7% | 40,945 | 0.0% | 0.02% | -30.4% |
| Q2 2019 | $2,104,000 | -12.5% | 40,945 | -2.4% | 0.02% | -11.5% |
| Q1 2019 | $2,404,000 | +36.6% | 41,945 | 0.0% | 0.03% | +13.0% |
| Q4 2018 | $1,760,000 | -44.4% | 41,945 | 0.0% | 0.02% | -23.3% |
| Q3 2018 | $3,167,000 | – | 41,945 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 1,459,128 | $110,164,000 | 6.60% |
| ArchPoint Investors | 224,187 | $16,926,000 | 4.60% |
| Redmile Group, LLC | 1,656,065 | $125,033,000 | 3.85% |
| WS MANAGEMENT LLLP | 954,812 | $72,088,000 | 2.37% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 342,000 | $25,821,000 | 1.19% |
| Perceptive Advisors | 470,672 | $35,536,000 | 0.95% |
| Pier Capital, LLC | 94,492 | $7,134,000 | 0.90% |
| Ipswich Investment Management Co., Inc. | 29,932 | $2,260,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 275,000 | $20,763,000 | 0.74% |
| Timpani Capital Management LLC | 27,835 | $2,102,000 | 0.61% |